Patent Issued for Method And Apparatus For Sleep Monitoring And Control (USPTO 10,980,472)

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily- A patent by the inventors Lack, Leon (Eden Hills, AU); Olsen, Benjamin (Austin, TX); Townsend, Vera (Ovingham, AU); Scott, Hannah (Adelaide, AU), filed on March 20, 2017, was published online on May 3, 2021, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 10,980,472 is assigned to Re-Time Pty Ltd. (Clovelly Park, Australia). The following quote was obtained by the news editors from the background information supplied by the inventors: "This invention relates to methods and apparatuses for sleep retraining. Particularly, this invention relates to methods and apparatuses for sleep retraining employing a user response to tactile stimulation. "Chronic insomnia is a sleep disorder that is associated with significant fatigue, irritability, decreased concentration and memory, increased risk of serious accidents and increased healthcare cost. Such consequences can incur significantly impaired quality of life for sufferers and an economic burden to society. "Pharmacotherapy remains a common treatment for chronic insomnia. However, Cognitive Behavioral Therapies (CBT) for insomnia can yield significantly greater benefits than pharmacotherapy and better long-term outcomes. Although benefits gained from pharmacological treatment are immediate, the medication provides symptomatic relief that is not sustained beyond the cessation of treatment. In contrast, the treatment benefits of CBT can remain beyond the termination of treatment.